1. All Products
  2. DVAC - Vaccines
  3. VACCINE Td (tetanus/diphtheria booster) 1 dose, multid. vial
Public Pricelist

VACCINE Td (tetanus/diphtheria booster) 1 dose, multid. vial

https://medicalguidelines.msf.org/en/node/982
https://unicat.msf.org/cat/product/12375
STD DVACVDTB1VD

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
19.3 - Vaccines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J07AM51
Anatomical Therapeutic Chemical Classification according to WHOCC
0208
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

VACCINE Td (tetanus/diphtheria booster)

CAUTION

This multidose vaccine is worded and codified by unit (= 1 dose) to make the order easier.

Therapeutic Action

Bivalent adsorbed vaccine containing purified tetanus and diphtheria toxoids (with a reduced dose of diphtheria component).

Indications

Prevention of tetanus in wound management
Prevention of tetanus and diphtheria in pregnant women or women of childbearing age
Prevention of tetanus and diphtheria in children over 4 years and adolescents (booster dose after complete primary vaccination)

Gradually replacing the TT vaccine (tetanus), including for women of childbearing age and pregnant women.

The choice between TT and Td vaccine will depend on which vaccine is introduced and registered in the country where it will be used.

Instructions for use

Suspension in liquid form

Shake the vial before use to homogenise the suspension.

Must be given by IM route into the deltoid muscle.

Follow the national immunisation schedule, or failing that, the WHO schedule.

The multidose vial is usually supplied by the Ministry of Health of the country concerned.

Orders are always done in number of doses and not in number of vials! (See Preliminary remarks on Vaccines)

Precautions for Use

As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.

Storage

  • Keep refrigerated between 2ºC and 8ºC
  • Do not freeze.
  • The vaccine vial monitor (VVM) is mandatory on each vaccine in multi-dose presentation.

(Cf Introduction: Thermosensitive products)